A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases
Z Hamidi, S Jabraeili-Siahroud, Y Taati-Alamdari… - Virology Journal, 2023 - Springer
After the first reporting of the index case of Severe Acute Respiratory Syndrome (SARS)-CoV-
2-associated disease at the end of December 2019, the virus spread quickly throughout the …
2-associated disease at the end of December 2019, the virus spread quickly throughout the …
Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 …
Background We estimated COVID-19 vaccine effectiveness against SARS-CoV-2 infection
and severe COVID-19 outcomes among individuals with immune-mediated inflammatory …
and severe COVID-19 outcomes among individuals with immune-mediated inflammatory …
Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation?
M Komine, TM Ansary, MR Hossain, K Kamiya… - International Journal of …, 2022 - mdpi.com
COVID-19 is a recently emerged viral infection worldwide. SARS-CoV-2, the causative virus,
is believed to have emerged from bat coronaviruses, probably through host conversion. The …
is believed to have emerged from bat coronaviruses, probably through host conversion. The …
Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory …
Q Wei, PJ Mease, M Chiorean, L Iles-Shih… - The Lancet Digital …, 2024 - thelancet.com
Background In the context of immune-mediated inflammatory diseases (IMIDs), COVID-19
outcomes are incompletely understood and vary considerably depending on the patient …
outcomes are incompletely understood and vary considerably depending on the patient …
[HTML][HTML] Risk factors for severe COVID-19 outcomes: a study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a …
Q Wei, PJ Mease, M Chiorean, L Iles-Shih, WF Matos… - Medrxiv, 2023 - ncbi.nlm.nih.gov
Background COVID-19 outcomes, in the context of immune-mediated inflammatory diseases
(IMIDs), are incompletely understood. Reported outcomes vary considerably depending on …
(IMIDs), are incompletely understood. Reported outcomes vary considerably depending on …
Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects
R Vollenberg, EU Lorentzen, J Kühn, TM Nowacki… - Vaccines, 2023 - mdpi.com
Introduction: The COVID-19 pandemic is a result of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). Vaccination against COVID-19 is crucial for preventing severe …
coronavirus 2 (SARS-CoV-2). Vaccination against COVID-19 is crucial for preventing severe …
Duration of Postvaccination Neutralizing Antibodies to SARS‐CoV‐2 and Medication Effects: Results from the Safety and Immunogenicity of COVID‐19 Vaccination in …
R Habib, RM Dayam, C Hitchon… - ACR Open …, 2024 - Wiley Online Library
Objective In the face of the ongoing circulation of SARS‐CoV‐2, the durability of
neutralization post–COVID‐19 vaccination in immune‐mediated inflammatory disease …
neutralization post–COVID‐19 vaccination in immune‐mediated inflammatory disease …
Comparison of the first and sixth waves of the SARS-COV-2 coronavirus pandemic in patients with immune-mediated disease
CL Rodríguez, AM López-Calleja… - … Clínica (English Edition), 2023 - Elsevier
Introduction Recent evidence shows that COVID-19 infection does not have a worse
prognosis in patients with immune-mediated inflammatory diseases (IMID), although they …
prognosis in patients with immune-mediated inflammatory diseases (IMID), although they …
COVID-19 und chronisch-entzündliche Darmerkrankungen
N Teich, A Stallmach - Die Gastroenterologie, 2023 - Springer
Zusammenfassung Die Pandemie durch die Coronavirus Disease 2019 (COVID-19)
beeinflusst weiter das Leben von Patient* innen mit chronisch-entzündlichen …
beeinflusst weiter das Leben von Patient* innen mit chronisch-entzündlichen …
COVID-19 and Health Outcomes in People with Multiple Sclerosis: A Population-Based Study in Italy
R Gnavi, I Eboli, PE Alboini, S D'Alfonso, R Picariello… - Life, 2023 - mdpi.com
People with multiple sclerosis (PWMS) are at high risk of being affected by the disruption of
health services that occurred during the COVID-19 pandemic months. The aim of this study …
health services that occurred during the COVID-19 pandemic months. The aim of this study …